BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vertex Pharmaceuticals Incorporated 

11010 Torreyana Road

San Diego  California  92121  U.S.A.
Phone: 858-404-6600 Fax: 858-404-6726


SEARCH JOBS





Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Vertex Pharmaceuticals is an Equal Opportunity Employer.

Key Contacts
Media: mediainfo@vrtx.com
Investors: investorinfo@vrtx.com
Patient Inquiries: clinical_trials@vrtx.com


This div will be replaced


 Key Statistics


Email:
Ownership:

Web Site: Vertex Pharmaceuticals (CA)
Employees:
Symbol: VRTX
 









 Company News
Fading Vertex Pharmaceuticals (CA) (VRTX) Drug Incivek was Also Fastest to Become a Blockbuster 11/1/2013 8:12:31 AM
GlobalDataWith the Threat of Competition Looming, Vertex Pharmaceuticals (MA) (VRTX) Boasts of Promising New HCV Therapy 8/2/2012 11:26:49 AM
Vertex Pharmaceuticals (CA) (VRTX): Phase 3 STRIVE Study of VX-770 Showed Durable Improvements in Lung Function (FEV1) and Other Measures of Disease Among People With a Specific Type of Cystic Fibrosis 6/10/2011 11:00:26 AM
Vertex Pharmaceuticals (CA) (VRTX) Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need 6/10/2011 10:28:22 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces Webcasts of its Presentations at Two Investor Conferences 5/27/2011 11:09:32 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces Webcasts of its Presentations at Two Investor Conferences 5/2/2011 9:13:31 AM
Vertex Pharmaceuticals (CA) (VRTX) Stock Trading Halted Amid FDA Review 4/28/2011 7:09:51 AM
Vertex Pharmaceuticals (CA) (VRTX) Rises After FDA Staff Says Hepatitis C Drug Is Effective 4/26/2011 11:32:29 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces the Date of its Full Year 2010 Financial Results Conference Call and Webcast 1/24/2011 8:10:33 AM
Vertex Pharmaceuticals (CA) (VRTX) Announces Key Business Objectives To Support Planned Launch of Telaprevir in Hepatitis C and Continued Progress in Other Serious Diseases 1/10/2011 11:41:57 AM
12345678